322 related articles for article (PubMed ID: 33259653)
1. The emerging role of immunotherapy for the treatment of sarcoma.
Klemen ND; Kelly CM; Bartlett EK
J Surg Oncol; 2021 Mar; 123(3):730-738. PubMed ID: 33259653
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
Nathenson MJ; Conley AP; Sausville E
Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in Sarcoma: Future Horizons.
Burgess M; Gorantla V; Weiss K; Tawbi H
Curr Oncol Rep; 2015 Nov; 17(11):52. PubMed ID: 26423769
[TBL] [Abstract][Full Text] [Related]
4. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
Zhu MMT; Shenasa E; Nielsen TO
Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapeutic approaches to sarcoma.
Burgess M; Tawbi H
Curr Treat Options Oncol; 2015 Jun; 16(6):26. PubMed ID: 25975445
[TBL] [Abstract][Full Text] [Related]
6. Potential for immunotherapy in soft tissue sarcoma.
Tseng WW; Somaiah N; Engleman EG
Hum Vaccin Immunother; 2014; 10(11):3117-24. PubMed ID: 25625925
[TBL] [Abstract][Full Text] [Related]
7. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas.
McCarthy EF
Iowa Orthop J; 2006; 26():154-8. PubMed ID: 16789469
[TBL] [Abstract][Full Text] [Related]
8. From vision to reality: deploying the immune system for treatment of sarcoma.
Wilky BA; Goldberg JM
Discov Med; 2017 Jan; 23(124):61-74. PubMed ID: 28245428
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy in soft-tissue sarcoma.
Ayodele O; Razak ARA
Curr Oncol; 2020 Feb; 27(Suppl 1):17-23. PubMed ID: 32174754
[TBL] [Abstract][Full Text] [Related]
10. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials.
Tang F; Tie Y; Wei YQ; Tu CQ; Wei XW
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188606. PubMed ID: 34371128
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy and Biomarkers in Sarcoma.
Dajsakdipon T; Siripoon T; Ngamphaiboon N; Ativitavas T; Dejthevaporn T
Curr Treat Options Oncol; 2022 Mar; 23(3):415-438. PubMed ID: 35262852
[TBL] [Abstract][Full Text] [Related]
12. The current landscape of early drug development for patients with sarcoma in the immunotherapy era.
Sebio A; Wilky BA; Keedy VL; Jones RL
Future Oncol; 2018 May; 14(12):1197-1211. PubMed ID: 29699407
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in Sarcoma: Current Data and Promising Strategies.
Wood GE; Meyer C; Petitprez F; D'Angelo SP
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432234. PubMed ID: 38781557
[TBL] [Abstract][Full Text] [Related]
14. Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
Carlson RD; Flickinger JC; Snook AE
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283684
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for sarcomas.
Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T
Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603
[TBL] [Abstract][Full Text] [Related]
16. The future of immunotherapy for sarcoma.
Tsukahara T; Emori M; Murata K; Mizushima E; Shibayama Y; Kubo T; Kanaseki T; Hirohashi Y; Yamashita T; Sato N; Torigoe T
Expert Opin Biol Ther; 2016 Aug; 16(8):1049-57. PubMed ID: 27158940
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy in sarcoma: a new frontier.
Wilky BA; Goldberg JM
Discov Med; 2014 Apr; 17(94):201-6. PubMed ID: 24759624
[TBL] [Abstract][Full Text] [Related]
18. Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional.
Borgatti A; Dickerson EB; Lawrence J
Vet Comp Oncol; 2020 Mar; 18(1):9-24. PubMed ID: 31749286
[TBL] [Abstract][Full Text] [Related]
19. Adoptive immunotherapy against sarcomas.
Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D
Expert Opin Biol Ther; 2015 Apr; 15(4):517-28. PubMed ID: 25516119
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of heterogenous sarcomas: questions and strategies.
Dufresne A; Meurgey A; Brahmi M
Curr Opin Oncol; 2019 Jul; 31(4):304-309. PubMed ID: 31033565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
